2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Distinct Patterns of Perivascular Diffusivity and Choroid Plexus Volume in De Novo Parkinson’s Disease and Type 2 Diabetes

YJ. Bae, C. Shin, H. Jeong, SJ. Cho, SH. Baik, DH. Lee, Y. Jeong, JM. Kim (Gainesville, USA)
Divergent Glymphatic Dysfunction and Free Water Pathology Underpin Distinct Mechanisms and Enable Differential Diagnosis in Parkinson’s Disease and Multiple System Atrophy

RNS. Shen, LCZ. Zhou, JL. Liu (Shanghai, China)
DJ-1 (PARK7) Heterozygous Mutation and Early-Onset Parkinson’s Disease: A Chilean Case Report and Literature Review

K. Guzmán, M. Sanchez, D. Avila (Santiago de Chile, Chile)
Do Digital Mobility Outcomes Differ Across Clinically Defined NSD-ISS Stages in Parkinson’s Disease?

P. Tait, L. Alcock, C. Schlenstedt, C. Caroll, C. Becker, J. Buekers, B. Caulfield, A. Cereatti, S. Del-Din, L. Delgado-Ortiz, J. Garcia-Aymerich, S. Koch, P. Ginis, H. Gassner, A. Nieuwboer, J. Hausdorf, A. Mirelman, L. Rochester, W. Maetzler, A. Yarnall (Newcastle upon Tyne, United Kingdom)
Does Balance Mediate the Relationship Between Aerobic Capacity and Walking Endurance in Parkinson’s Disease?

C. Balasubramaniam, I. Wilkinson, J. Osborne, K. Flanagan, K. Mangipudi (Jacksonville, USA)
Does CANVAS mimic MSA-C

I. Pei, A. Storck, T. Bogdan, C. Tranchant, IJ. Namer, S. Kremer, T. Thomas, M. Anheim (Strasbourg, France)
Does Fall-Related Activity Avoidance Differ between people with Parkinson’s disease versus Cognitively Unimpaired Controls?

M. Lindh-Rengifo, E. Franzén, M. Landers, E. Stomrud, M. Nilsson (Lund, Sweden)
Does Fgatir Hypointensity Predict Outcomes After Deep Brain Stimulation For Action Tremors

N. Kahn, S. Abdelaziz1, F. Baig, I. Cociasu, B. Ishihara, S. Ratti, L. Ricciardi, E. Pereira, F. Morgante, M. Hart (Cairo, Egypt)
Does Knowing More Mean Tolerating More? Satisfaction with Medication Information and Levodopa Dosage in Parkinson’s Disease

M. da Silva, M. Tosin, L. Silveira-Moriyama (Chicago, USA)
Does PET Imaging Modality Influence Artificial Intelligence Performance in Diagnosing Parkinson’s Disease? Diagnostic Test Accuracy Meta-analysis

MH. Elkasaby, MSA. Ahmed (Cairo, Egypt)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z